Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MAC Bioventures is the venture capital and incubation arm of MAC Clinical Research, a leading UK-based contract research organization (CRO). The firm specializes in identifying and supporting early-stage life science companies, particularly those focused on central nervous system (CNS) disorders, pain management, and respiratory health. MAC Bioventures utilizes a unique "clinical-trial-services-for-equity" model, providing biotech startups with access to MAC's extensive clinical infrastructure and expertise in exchange for an ownership stake. This integrated approach helps de-risk drug development and accelerates the path from pre-clinical research to clinical proof-of-concept. The company's portfolio includes several innovative biotechs developing novel therapies for high-need indications such as Alzheimer's disease and depression.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mac Bioventures.